MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Marker Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.20+0.16 (+15.38%)
Close on Oct 19, 2026
- Market cap
- $23.18M
- P/E (TTM)
- –
- Dividend yield
- –
Marker Therapeutics, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPRIT Pancreatic Grant | $251.66K | – | – | – | $12.54K | – | – | – | – | – | – | – | 33.5% | +1906.2% |
| CPRIT AML | $208.51K | – | – | – | $217.64K | – | – | – | – | – | – | – | 27.7% | -4.2% |
| SBIR AML | $116.50K | $172.21K | $200.00K | $12.00K | $96.72K | $282.18K | $300.00K | $200.00K | $200.00K | – | – | – | 15.5% | +20.4% |
| National Institutes of Health National - Cancer Institute Grant | $98.63K | $91.31K | $100.00K | $200.00K | $14.22K | – | – | – | – | – | – | – | 13.1% | +593.8% |
| SBIR pancreatic cancer grant | $73.48K | $225.67K | $200.00K | $100.00K | $7.98K | – | – | – | – | – | – | – | 9.8% | +820.9% |
| FDA Grant | $2.90K | $18.48K | $10.00K | $100.00K | $0 | $19.75K | $20.00K | $200.00K | $300.00K | $200.00K | $0 | $100.00K | 0.4% | – |
| Grant income | – | $1.10M | $1.23M | $861.18K | $349.10K | $2.25M | $1.93M | $1.17M | $1.24M | $1.06M | $257.61K | $762.66K | – | – |
| CPRIT grant | – | – | $200.00K | $300.00K | $200.00K | $2.00M | $900.00K | $700.00K | $800.00K | $700.00K | $200.00K | $700.00K | – | – |
| SBIR lymphoma grant | – | $65.00K | $600.00K | $0 | $0 | $0 | $700.00K | – | – | – | – | – | – | – |
| Additional CPRIT grant | – | – | $0 | $200.00K | $13.00K | – | – | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Marker Therapeutics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.